SCHEMBL9892670

SCHEMBL9892670

N#Cc1c(-c2ccccc2CC(N)=O)cccc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.40
MAOB P27338 1/20 0.38
PARP1 P09874 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
POLQ O75417 1/20 0.36
AR P10275 1/20 0.36
PTGS2 P35354 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
CACNA1B Q00975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9892660 0.83 MAOB (0.44) MAOBPARP1POLQPTGS2ALDH1A1
SCHEMBL1395805 0.76 POLQ (0.55) MAOBLMNAPOLQPTGS2ALDH1A1
SCHEMBL9890759 0.76 MAOB (0.38) MAOBPARP1POLQPTGS2ALDH1A1
Hydrochloric Acid SCHEMBL8413702 0.75 POLQ (0.54) MAOBPOLQPTGS2ALDH1A1GAA
SCHEMBL9892668 0.73 POLQ (0.45) POLQALDH1A1
SCHEMBL9892664 0.73 CHRM5 (0.41) P2RX7MAOBLMNAALDH1A1HPGD
SCHEMBL31645651 0.72 P2RX7 (0.47) P2RX7MAOBPOLQPTGS2IDO1
SCHEMBL7000495 0.72 MAOB (0.42) P2RX7MAOBPOLQPTGS2GAA
SCHEMBL2393509 0.72 POLQ (0.43) SMN1; SMN2LMNAPOLQALDH1A1KDM4E
SCHEMBL30462467 0.72 TAS2R14 (0.43) PARP1ALDH1A1KDM4EMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
EP-2374790-A1 BIPHENYLACETAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 P2RX7 1015/4885MAOB 1411/4885PARP1 3158/4885
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 P2RX7 1015/4885MAOB 1411/4885PARP1 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.